Abstract:BACKGROUND: The DYNC1H1 gene encodes a part of the dynamic protein, and the protein mutations may further affect the growth and development of neurons, resulting in degeneration of anterior horn cells of the spinal cord, and a variety of clinical phenotypes finally resulting in axonal Charcot-Marie-Tooth disease type 20 (CMT20), mental retardation 13 (MRD13) and spinal muscular atrophy with lower extremity predominant 1 (SMA-LED). The incidence of the disease is low, and it is difficult to diagnose, especially in children. Here, we report a case of DYNC1H1 gene mutation and review the related literature to improve the pediatrician's understanding of DYNC1H1 gene-related disease to make an early correct diagnosis and provide better services for children.CASE SUMMARY: A 4-mo-old Chinese female child with adducted thumbs, high arch feet, and epileptic seizure presented slow response, delayed development, and low limb muscle strength. Electroencephalogram showed abnormal waves, a large number of multifocal sharp waves, sharp slow waves, and multiple spasms with a series of attacks. High-throughput sequencing and Sanger sequencing identified a heterozygous mutation, c.5885G>A (p.R1962H), in the DYNC1H1 gene (NM_001376) of the proband, which was not identified in her parents. Combined with the clinical manifestations and pedigree of this family, this mutation is likely pathogenic based on the American Academy of Medical Genetics and Genomics guidelines. The child was followed when she was 1 year and 2 mo old. The magnetic resonance imaging result was consistent with the findings of white matter myelinated dysplasia and congenital giant gyrus. The extensive neurogenic damage to the extremities was considered, as the results of electromyography showed that the motor conduction velocity and sensory conduction of the nerves of the extremities were not abnormal, and the degree of fit of the children with severe contraction was poor. At present, the child is 80 cm in length and 9 kg in weight, with slender limbs and low muscle strength, and still does not raise her head. She cannot sit or speak. Speech, motor, and mental development was significantly delayed. There is still no effective treatment for this disease.CONCLUSION: We herein report a de novo variant of DYNC1H1 gene, c.5885G>A (p.R1962H), leading to overlapping phenotypes (seizure, general growth retardation, and muscle weakness) of CMT20, MRD13, and SMA-LED, but there is no effective treatment for such condition. Our case enriches the DYNC1H1 gene mutation spectrum and provides an important basis for clinical diagnosis and treatment and genetic counseling.

Nemaline Myopathy With a Compound Heterozygous Mutation: A Case Report

Identification of LAMA2 Compound Heterozygous Variants: a Case Report

A Cross-Sectional Study of Nemaline Myopathy

Nemaline myopathy with scoliosis: a case report

Clinico-pathological features and mutational spectrum of 16 nemaline myopathy patients from a Chinese neuromuscular center

[Clinical and Pathologic Analysis of an Autosomal Recessive Kindred with Nemaline Myopathy].

A Case of a Newborn With Nemaline Myopathy From Al-Qunfudhah City, Saudi Arabia

Mutational and clinical spectrum in a cohort of Chinese patients with hereditary nemaline myopathy.

Rare Abnormality of Pyramidal Tract and Oligospermia As a Presenting Sign of Nemaline Myopathies: A Case Report

Novel Compound Heterozygous Mutations in a GNE Myopathy with Congenital Thrombocytopenia: A Case Report and Literature Review.

Case report: A novel ACTA1 variant in a patient with nemaline rods and increased glycogen deposition

Phenotype variability and histopathological findings in patients with a novel DNM2 mutation.

L-tyrosine for treatment of an infant with nemaline rod myopathy

Characterization of NEB pathogenic variants in patients reveals novel nemaline myopathy disease mechanisms and omecamtiv mecarbil force effects

A rare TNNT1 gene variant causing creatine kinase elevation in nemaline myopathy: c.271_273del (p.Lys91del)

Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes with coexisting nemaline myopathy: a case report

ACTA1 H40Y mutant iPSC-derived skeletal myocytes display mitochondrial defects in an in vitro model of nemaline myopathy

A Discussion on Clinical and Pathological Features and Pathogenesis of Nemaline Myopathy (NM)

TNNT1 nemaline myopathy: natural history and therapeutic frontier

A Likely Pathogenic variant in the KBTBD13 Gene: A Case Series of Three Patients with Nemaline Myopathy Type 6

Missense mutation in DYNC1H1 gene caused psychomotor developmental delay and muscle weakness: A case report